Approvals/TGA/NALOXONE JUNO NEONATAL naloxone hydrochloride (as dihydrate) 40 micrograms/2 mL solution for injection, ampoule

Approved

STANDARD

NALOXONE JUNO NEONATAL naloxone hydrochloride (as dihydrate) 40 micrograms/2 mL solution for injection, ampoule

Juno Pharmaceuticals Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: 2b2a9643cc65a047
Product Name: NALOXONE JUNO NEONATAL naloxone hydrochloride (as dihydrate) 40 micrograms/2 mL solution for injection, ampoule
Artg Id: 236003
Artg Name: NALOXONE JUNO NEONATAL naloxone hydrochloride (as dihydrate) 40 micrograms/2 mL solution for injection, ampoule
Sponsor: Juno Pharmaceuticals Pty Ltd
Company Detail Path: /organization/juno-pharmaceuticals-pty-ltd
Artg Date: 2016-03-10
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Consumer Medicine Info: https://medical-cdn.nocode.com/drug_tga/59e0f051b2b9f54222ded25404f599b7.pdf
Product Information: https://medical-cdn.nocode.com/drug_tga/930c321520acf72d0dfe795673c17845.pdf

Approved

Agency

TGA

Country

🇦🇺

Approval Date

May 29, 2025

Approval ID

2b2a9643cc65a047

Type

Standard